Joined November 2011
75 Photos and videos
Excellent turnout and meaningful conversations at the breakfast round table about #ACHD program building at the 35th International Symposium on ACHD @WMCHealth @nymedcollege @WMCCardsFellows
2
105
Georges Ephrem retweeted
In my opinion, this is a very important mission for @SCAI and @JDawnAbbott1 is the right person to lead this effort.
Apr 25
In her vision for the field, J. Dawn Abbott, MD, MSCAI, highlights a key shift: growth in training programs isn’t always matched by applicant trends. The Match is bringing needed visibility to workforce dynamics shaping #InterventionalCardiology. #SCAI2026 #SCAIFellowshipMatch @JDawnAbbott1
3
15
92
11,621
Georges Ephrem retweeted
The future of EP is bright ⚡️ Incredible showing by the WMC EP Fellows and @WMCCardsFellows at #HRS2026. Presenting several abstracts, learning, contributing, and leading! Great night celebrating this crew 🍽️ @HRSonline
1
7
23
1,265
Every one of us should do their part in fostering vocations in #ACHD #Interventions! Excellent job by @dhrupat97! @AdaStefanescuMD @JGhobrialMD @SimranSinghMD @EeLingHeng1 @HuieLin @erichorlick @Markosten2 @serfasj @allison_tsao
1
6
470
“Meet the Masters” Networking Session at #SCAI2026. Privileged to be in such esteemed company @SrihariNaiduMD @SripalBangalore @SCAI @WMCHealth @WMCCardsFellows @nymedcollege
3
10
653
“Mind the Gap: PFO, Stroke, and the Brain-Heart Connection” @SCAI 2026 @WMCCardsFellows @WMCHealth @nymedcollege @AdaStefanescuMD @_WayneBatchelor @docsaw
1
4
353
Emotional and inspiring Presidential Address by @SrihariNaiduMD! A year of remarkable accomplishments and a launching pad to a brilliant legacy! @SCAI @scaielm @WMCHealth @nymedcollege
1
3
8
484
Georges Ephrem retweeted
Great session on an under utilized test. Sometimes our valvular heart disease patients can benefit - when unsure about dyspnea on exertion: CPET (cardiopulmonary exercise stress testing) @ACCinTouch #ACC26
1
3
200
It’s always unique to catch up with this stellar group of friends! @aklfahed @Dr_AbuDaya @Michel_CorbanMD To @AkramWIbrahim and @salimhayek you were sorely missed!
1
3
9
705
Our star resident Rimsha Ahmad presenting at #ACC2026 @ACCinTouch @WMCHealth @WMCCardsFellows @nymedcollege
5
17
1,305
Georges Ephrem retweeted
Come! All star panel!
Starting 8:30 top trials on IC at #ACC26 @SCAI and again later today. See ya there!
2
19
2,433
Excellent turnout and meaningful in-depth discussions at #ACC #FIT Mix and Mingle #ACHD! Privileged to share the stage with my dear friend and esteemed colleague @AdaStefanescuMD! @WMCHealth @nymedcollege @CardioNerds @ACHA_Heart
3
111
Don’t forget to check out the #ACHD table!
Always a fun event. Please come and mingle. Explore the different fields within cardiology and ask questions! #ACC26
1
1
375
Great running into my esteemed friend @DrMarwanRefaat at #ACC26! Congratulations on your continued achievements at my Alma mater @AUB_Lebanon @AUBMC_Official
1
15
1,101
Georges Ephrem retweeted
Just got to Philly for grand rounds tomorrow at the place that trained me. Hearing I might be the first alum to leave & be invited back since then. Regardless a total honor. Dinner w faculty then drinks w @PennCardiology fellows. If you’re a fellow, come. I’ve got stories 😉
5
9
90
10,347
Privileged to give #cardiology #grandrounds @WMCHealth about #ACHD! Much to do to disseminate awareness about the field and this unique patient population! @ACHA_Heart @nymedcollege @ISACHD @NYSCACC @AHANewYorkCity @AHANewYork
1
1
14
881
Wrapping up #CRT2026 talking about “New Pulmonic Valves and IVL in Pulmonary Interventions | An Update” and then joining world class experts in the field such as @hahn_rt & Hans Figulla for panel discussion! Thank you @ronwaksman & until next year’s 30 year anniversary for #CRT!
2
7
251
Georges Ephrem retweeted
Congrats for the investigators. This would certainly deserve further investigation and understanding. Can’t understand improved PVL mechanism which rates are quite high. Is this published anywhere?
Late-breaking trial at #CRT2026: Tirzepatide after TAVR substanially reduced HALT and PVL at 12 months. Highlights: • HALT: 8.4% vs 21.6% (RR 0.39, p=0.002) • PVL: 10.7% vs 25.3% • SLT progression: 3.1% vs 11.5% • Lower mean gradient, better EOA • No unexpected safety signal A metabolic therapy entering the structural valve conversation. Next steps: further sensitivity analysis looking at the impact of the degree of weightloss on HALT? Are the results solely due to weight loss, anti-inflammatory or other mechanims? Great work by Dr. Thirugnanam and team! #TAVR #StructuralHeart #GLP1 #CardioX @crt_meeting @ron_waksman @GreggWStone @TheDoctorMack @KarenMKimMD1 @PopmaJeffrey @MReardon19 @SachinGoelMD
1
3
31
8,913